![Quiver Logo](/static/img/logo-icon.png)
![SCNI logo](https://quiver-logos.s3.us-east-2.amazonaws.com/scni.png)
Scinai Immunotherapeutics Ltd. American Depositary Shares
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SCNI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of SCNI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SCNI's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SCNI
Recent picks made for SCNI stock on CNBC
ETFs with the largest estimated holdings in SCNI
Flights by private jets registered to SCNI
![Quiver Logo](/static/img/logo-icon.png)